TAB1 Antilichaam
Gecertificeerd

TAB1 Antilichaam

Catalog #: 3387-01
Maat: 0.02 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

TAB1 Antibody: TAB1 was identified as a regulator of the MAP kinase kinase kinase TAK1/MAP3K7, which is known to mediate various intracellular signaling pathways, such as those induced by TGF-beta and members of the Toll-IL-1R (TIR) superfamily, thus acting as an intermediate in both proliferative and innate and adaptive immune responses. This protein, together with either TAB2 or TAB3, activates TAK1 kinase in response to upstream signals. It has been shown that the C-terminal portion of TAB1 is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF-beta, demonstrating how this protein can function as a mediator between TGF-beta receptors and TAK1.

NCBI Gene ID

10454

Swiss Prot

Q15750

Accession Number

NP_006107

Host

• Rabbit

Reactivity

Human, Mouse

Clonality

• Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Innate Immunity

Purification

TAB1 Antibody is affinity chromatography purified via peptide column.

Positive Control

Cat. No. 1212 - 3T3 Cell Lysate

Concentration

1 mg/mL

Buffer

TAB1 Antibody is supplied in PBS containing 0.02% sodium azide.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

TAB1 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Fragment

IgG

Symbol

TAB1

Positive Control 2

Cat. No. 1204 - K562 Cell Lysate

Positive Control 3

Cat. No. 17-004 - K-562 Cell Slide

Positive Control 4

Cat. No. 17-201 - 3T3/BALB Cell Slide

NCBI Official Name

TGF-beta activated kinase 1 (MAP3K7) binding protein 1

NCBI Organism

Homo sapiens

Background Reference 01

Shibuya H, Yamaguchi K, Shirakabe K, et al. TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 1996; 272:1179-82.

Background Reference 02

Irie T, Muta T, and Takeshige K. TAK1 mediates an activation signal from toll-like receptor (s) to nuclear factor-κ B in lipopolysaccharide-stimulated macrophages. FEBS Lett. 2000; 467:160-4.

Background Reference 03

Akira S and Takeda K. Toll-like receptor Signalling. Nat. Rev. Immunol. 2004; 4:499-511.

Background Reference 04

Jiang Z, Ninomiya-Tsuji J, Qian Y, et al. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 2002; 22:7158-67.

Other Product Names

TAB1 Antibody: 3'-Tab1, MAP3K7IP1, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1, Mitogen-activated protein kinase kinase kinase 7-interacting protein 1, TAK1-binding protein 1

Tested Applications

ELISA, WB, ICC, IF

Protein ID

5174703

Physical Properties

Liquid

Beschrijving

TAB1 Antilichaam Beschikbaar in 0.02 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamTAB1 Antilichaam
Categorie
Beschikbare grootte0.02 mg
Catalogusnummer3387-01